» Articles » PMID: 19786254

Central Aortic Stiffness is Increased in Patients with Heart Failure and Preserved Ejection Fraction

Overview
Journal J Card Fail
Date 2009 Sep 30
PMID 19786254
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypertension is an important risk factor for the development of heart failure with preserved ejection fraction. Although heart failure in hypertensive patients is usually ascribed to intrinsic myocardial abnormalities, noncardiac factors may contribute.

Methods And Results: Using arterial tonometry and Doppler echocardiography, we assessed arterial stiffness and cardiac diastolic function in 53 individuals with ejection fraction >or=0.50, including 23 with hypertension but no heart failure, 16 with hypertension and heart failure, and 14 healthy, normotensive controls. Relative to healthy controls and hypertensives, subjects with heart failure had higher systolic blood pressure, body mass index, creatinine, and left ventricular mass. Diastolic function, as estimated by myocardial relaxation velocity, was not different among the 3 groups. Peripheral arterial stiffness was similar across all groups, but key measures of central aortic stiffness (carotid-femoral pulse wave velocity, characteristic impedance, forward wave amplitude) steadily increased with progression from healthy to hypertensive to heart failure despite adjustment for body mass index, systolic blood pressure, and renal function and were positively correlated with both left ventricular mass and filling pressure.

Conclusions: We conclude that patients with heart failure and preserved ejection fraction have increased central aortic stiffness relative to age-matched healthy and hypertensive subjects without heart failure. These changes exceed differences in diastolic function and suggest that abnormal ventricular-vascular coupling may contribute to the pathophysiology of heart failure with preserved ejection fraction.

Citing Articles

Augmentation index as a predictor of right ventricular dysfunction in coronary artery disease: a cross-sectional study.

Rahimi A, Geraiely B, Vahidi H, Eftekhari M, Rahimi Darehbagh R, Mohammadi S BMC Cardiovasc Disord. 2025; 25(1):71.

PMID: 39893481 PMC: 11786491. DOI: 10.1186/s12872-024-04444-3.


Mineralocorticoid receptor antagonists and heart failure with preserved ejection fraction: current understanding and future prospects.

Chen X, Huang M, Chen Y, Xu H, Wu M Heart Fail Rev. 2024; 30(1):191-208.

PMID: 39414721 DOI: 10.1007/s10741-024-10455-1.


The association between pulse wave velocity and heart failure: a systematic review and meta-analysis.

Esmaeili Z, Bahiraie P, Vaziri Z, Azarboo A, Behnoush A, Khalaji A Front Cardiovasc Med. 2024; 11:1435677.

PMID: 39108667 PMC: 11301612. DOI: 10.3389/fcvm.2024.1435677.


Inversion of Left Ventricular Axial Shortening: In Silico Proof of Concept for Treatment of HFpEF.

Goetz W, Yao J, Brener M, Puri R, Swaans M, Schopka S Bioengineering (Basel). 2024; 11(7).

PMID: 39061758 PMC: 11274197. DOI: 10.3390/bioengineering11070676.


The Stiffness of the Ascending Aorta Has a Direct Impact on Left Ventricular Function: An In Silico Model.

Goetz W, Yao J, Brener M, Puri R, Swaans M, Schopka S Bioengineering (Basel). 2024; 11(6).

PMID: 38927839 PMC: 11200724. DOI: 10.3390/bioengineering11060603.